Dr. David Davis, MD

NPI: 1730267717
Total Payments
$3,857
2024 Payments
$589.81
Companies
13
Transactions
120

Payment Breakdown by Category

Food & Beverage$3,857 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $3,857 120 100.0%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $1,528 64 $0 (2024)
Axsome Therapeutics, Inc. $620.42 5 $0 (2024)
Bausch Health US, LLC $436.82 26 $0 (2021)
Intuitive Surgical, Inc. $332.39 1 $0 (2020)
Allergan, Inc. $281.25 11 $0 (2020)
Otsuka America Pharmaceutical, Inc. $229.10 2 $0 (2018)
IDORSIA PHARMACEUTICALS US INC $121.63 1 $0 (2022)
Takeda Pharmaceuticals U.S.A., Inc. $112.65 1 $0 (2019)
Adlon Therapeutics L.P. $92.34 4 $0 (2021)
Brainsway USA INC $45.19 1 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $589.81 12 Axsome Therapeutics, Inc. ($375.00)
2023 $725.44 21 AbbVie Inc. ($480.02)
2022 $407.55 15 ABBVIE INC. ($285.92)
2021 $730.26 30 AbbVie Inc. ($592.56)
2020 $843.28 24 Intuitive Surgical, Inc. ($332.39)
2019 $280.54 12 Bausch Health US, LLC ($126.26)
2018 $171.32 5 Otsuka America Pharmaceutical, Inc. ($120.77)
2017 $108.33 1 Otsuka America Pharmaceutical, Inc. ($108.33)

All Payment Transactions

120 individual payment records from CMS Open Payments — Page 3 of 5

Date Company Product Nature Form Amount Type
11/04/2021 AbbVie Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $28.63 General
Category: NEUROSCIENCE
10/28/2021 AbbVie Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $22.15 General
Category: NEUROSCIENCE
10/01/2021 AbbVie Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $18.80 General
Category: NEUROSCIENCE
09/29/2021 AbbVie Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $27.02 General
Category: NEUROSCIENCE
09/17/2021 AbbVie Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $23.30 General
Category: NEUROSCIENCE
08/21/2021 AbbVie Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $20.04 General
Category: NEUROSCIENCE
08/06/2021 AbbVie Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $27.00 General
Category: NEUROSCIENCE
08/06/2021 AbbVie Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $14.09 General
Category: NEUROSCIENCE
07/30/2021 Merck Sharp & Dohme Corporation BELSOMRA (Drug) Food and Beverage In-kind items and services $16.27 General
Category: NEUROSCIENCE
07/26/2021 AbbVie Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $23.65 General
Category: NEUROSCIENCE
07/17/2021 AbbVie Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $24.25 General
Category: NEUROSCIENCE
07/14/2021 Bausch Health US, LLC APLENZIN (Drug) Food and Beverage In-kind items and services $24.61 General
Category: Neurology
07/02/2021 AbbVie Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $23.87 General
Category: NEUROSCIENCE
06/24/2021 Adlon Therapeutics L.P. ADHANSIA XR (Drug) Food and Beverage Cash or cash equivalent $24.03 General
Category: PRESCRIPTION STIMULANT
05/28/2021 AbbVie Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $25.53 General
Category: NEUROSCIENCE
05/28/2021 AbbVie Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $17.50 General
Category: NEUROSCIENCE
04/26/2021 AbbVie Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $16.69 General
Category: NEUROSCIENCE
03/25/2021 AbbVie Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $22.38 General
Category: NEUROSCIENCE
03/19/2021 AbbVie Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $25.40 General
Category: NEUROSCIENCE
03/19/2021 AbbVie Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $15.10 General
Category: NEUROSCIENCE
03/15/2021 Bausch Health US, LLC APLENZIN (Drug) Food and Beverage In-kind items and services $22.20 General
Category: Neurology
03/10/2021 Bausch Health US, LLC APLENZIN (Drug) Food and Beverage In-kind items and services $15.76 General
Category: Neurology
03/01/2021 AbbVie Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $22.33 General
Category: NEUROSCIENCE
02/08/2021 AbbVie Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $20.14 General
Category: NEUROSCIENCE
02/05/2021 AbbVie Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $26.30 General
Category: NEUROSCIENCE

About Dr. David Davis, MD

Dr. David Davis, MD is a Psychiatry healthcare provider based in Newport Beach, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1730267717.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Davis, MD has received a total of $3,857 in payments from pharmaceutical and medical device companies, with $589.81 received in 2024. These payments were reported across 120 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($3,857).

Practice Information

  • Specialty Psychiatry
  • Location Newport Beach, CA
  • Active Since 11/01/2006
  • Last Updated 07/08/2007
  • Taxonomy Code 2084P0800X
  • Entity Type Individual
  • NPI Number 1730267717

Products in Payments

  • VRAYLAR (Drug) $1,809
  • Auvelity (Drug) $620.42
  • APLENZIN (Drug) $411.04
  • Da Vinci Surgical System (Device) $332.39
  • REXULTI (Drug) $229.10
  • QUVIVIQ (Drug) $121.63
  • TRINTELLIX (Drug) $112.65
  • ADHANSIA XR (Drug) $92.34
  • Brainsway Deep TMS System (Device) $45.19
  • MYDAYIS (Drug) $26.73
  • WELLBUTRIN (Drug) $25.78
  • BELSOMRA (Drug) $16.27
  • SPRAVATO (Drug) $13.62

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Psychiatry Doctors in Newport Beach